TARDBP and proteostasis deficiencies: Importantly, the coalescence of SOD1, TDP-43 and p62 proteinopathies has not been assessed in vitro or in vivo to date, and may inform on novel therapeutic approaches capable of slowing or halting the development of multiple damaging co-pathologies.